Abstract
Purpose
To compare the safety and efficiency of thulium laser resection of the prostate-tangerine technique (TmLRP-TT) and plasmakinetic resection of the prostate (PKRP) for aged symptomatic benign prostatic hyperplasia (BPH) patients with large volume prostates (>80 ml) in a prospective randomized trial with an 18-month follow-up.
Materials and methods
From January 2010 to November 2011, 90 BPH patients with large volume prostates were randomized for surgical treatment with TmLRP-TT (n = 45, group 1) or PKRP (n = 45, group 2). The preoperative and postoperative parameters were recorded and compared. All patients were evaluated at 1, 6, 12 and 18 months postoperatively using the International Prostate Symptom Score (IPSS), quality of life score (QoL), maximum flow rate (Q max), postvoid residual urine volume (PVR) and the five-item version of the International Index of Erectile Function score. All perioperative complications were also documented and classified according to the modified Clavien classification system.
Results
Compared with the PKRP group, the TmLRP-TT group had a statistically lower hemoglobin drop (0.86 ± 0.42 vs. 1.34 ± 1.04 g/dl, P < 0.01), shorter catheterization time (1.91 ± 0.85 vs. 2.36 ± 0.74 days, P < 0.01) and hospital stay (3.80 ± 0.46 vs. 5.02 ± 0.54 days, P < 0.01). Within the observation period of 18 months, both groups had significant postoperative improvement in IPSS, QoL, Q max and PVR, although no difference was observed between the two groups. Only one patient receiving PKRP treatment required a blood transfusion perioperatively. During the 18-month follow-up, one patient in each group experienced urethral stricture and one patient in the PKRP group experienced bladder neck contracture. Minor complications that required no or noninterventional treatment occurred in 6 (13.33 %) of TmLRP-TT group (Clavien grade 1, 13.33 % and grade 2, 0 %) and 10 (22.22 %) of PKRP group (Clavien grade 1, 20.00 % and grade 2, 2.22 %). No severe complications required reinterventions in both groups (Clavien grade 3, 0 %; grade 4, 0 %; grade 5, 0 %).
Conclusions
Both TmLRP-TT and PKRP are safe and effective treatment options for large prostates that require resection. Taking into account less blood loss, shorter catheterization time and hospital stay, TmLRP-TT may be a better treatment for patients with large prostates.
Similar content being viewed by others
References
Patel A, Adshead JM (2004) First clinical experience with new transurethral bipolar prostate electrosurgery resection system: controlled tissue ablation (coblation technology). J Endourol 18(10):959–964
Alivizatos G, Skolarikos A, Chalikopoulos D, Papachristou C, Sopilidis O, Delis A, Kastriotis I, Deliveliotis C (2008) Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol 54(2):427–437
Tubaro A, Nunzio C (2006) The current role of open surgery in BPH. Eau-Ebu Update Ser 4(5):191–201
Nuhoglu B, Ayyildiz A, Karaguzel E, Cebeci O, Germiyanoglu C (2006) Plasmakinetic prostate resection in the treatment of benign prostate hyperplasia: results of 1-year follow up. Int J Urol 13(1):21–24
Zhu L, Chen S, Yang S, Wu M, Ge R, Wu W, Liao L, Tan J (2013) Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup. J Urol 189(4):1427–1431
Zhu G, Xie C, Wang X, Tang X (2012) Bipolar plasmakinetic transurethral resection of prostate in 132 consecutive patients with large gland: three-year follow-up results. Urology 79(2):397–402
Finley DS, Beck S, Szabo RJ (2007) Bipolar saline TURP for large prostate glands. Sci World J 7:1558–1562
Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 19(1):25–31
Fried NM (2005) High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 microm. Lasers Surg Med 36(1):52–56
Xia SJ, Zhang YN, Lu J, Sun XW, Zhang J, Zhu YY, Li WG (2005) Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia. Zhonghua Yi Xue Za Zhi 85(45):3225–3228
Xia SJ (2009) Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. Asian J Androl 11(3):277–281
Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389
Wei HB, Zhuo J, Sun XW, Pang K, Shao Y, Liang SJ, Cui D, Zhao FJ, Yu JJ, Xia SJ (2013) Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates. Lasers Med Sci. doi:10.1007/s10103-013-1437-8
Hermanns T, Fankhauser CD, Hefermehl LJ, Kranzbühler B, Wong LM, Capol JC, Zimmermann M, Sulser T, Müller A (2013) Prospective evaluation of irrigation fluid absorption during pure transurethral bipolar plasma vaporization of the prostate using expired-breath ethanol measurements. BJU Int 112(5):647–654
Lepor H (2004) Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol 6(Suppl 9):S3–S10
Bach T, Netsch C, Haecker A, Michel MS, Herrmann TR, Gross AJ (2010) Thulium: YAG laser enucleation (VapoEnucleaion) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28(1):39–43
Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, Ndow J, Nordling J, de la Rosette JJ (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118–140. doi:10.1016/j.eururo.2013.03.004
Tan A, Liao C, Mo Z, Cao Y (2007) Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 94(10):1201–1208
Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53(1):160–166
Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, Cestari A, Briganti A, Mazzocoli B, Rigatti P, Montorsi F (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50(3):563–568
Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR (2012) Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int 109(3):408–411
Elzayat EA, Elhilali MM (2007) Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol 52(5):1465–1471
Ubee SS, Philip J, Nair M (2011) Bipolar technology for transurethral prostatectomy. Expert Rev Med Devices 8(2):149–154
Bach T, Xia SJ, Yang Y, Mattioli S, Watson GM, Gross AJ, Herrmann TR (2010) Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168
Gross AJ, Netsch C, Knipper S, Holzel J, Bach T (2013) Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol 63(5):859–867
Peng B, Wang GC, Zheng JH, Xia SQ, Geng J, Che JP, Yan Y, Huang JH, Xu YF, Yang B et al (2013) A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia. BJU Int 111(4):633–637
de Sio M, Autorino R, Quarto G, Damiano R, Perdona S, di Lorenzo G, Mordente S, D’Armiento M (2006) Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial. Urology 67(1):69–72
Netsch C, Bach T, Herrmann TR, Gross AJ (2012) Thulium:YAG VapoEnucleation of the prostate in large glands: a prospective comparison using 70- and 120-W 2-microm lasers. Asian J Androl 14(2):325–329
Zhang FB, Shao Q, Herrmann TR, Tian Y, Zhang Y (2012) Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology 79(4):869–874
Greene DR, Egawa S, Hellerstein DK, Scardino PT (1990) Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia. Urology 36(4):293–299
Franciosi M, Koff WJ, Rhoden EL (2007) Correlation between the total volume, transitional zone volume of the prostate, transitional prostate zone index and lower urinary tract symptoms (LUTS). Int Urol Nephrol 39(3):871–877
Iacono F, Prezioso D, Di Lauro G, Romeo G, Ruffo A, Illiano E, Amato B (2012) Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients. BMC Surg 12(Suppl 1):S21
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wei, H., Shao, Y., Sun, F. et al. Thulium laser resection versus plasmakinetic resection of prostates larger than 80 ml. World J Urol 32, 1077–1085 (2014). https://doi.org/10.1007/s00345-013-1210-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-013-1210-4